124 related articles for article (PubMed ID: 8220441)
1. Individual variability in p-aminobenzoic acid N-acetylation by human N-acetyltransferase (NAT1) of peripheral blood.
Weber WW; Vatsis KP
Pharmacogenetics; 1993 Aug; 3(4):209-12. PubMed ID: 8220441
[No Abstract] [Full Text] [Related]
2. Arylamine N-acetyltransferase 1 in situ N-acetylation on CD3+ peripheral blood mononuclear cells correlate with NATb mRNA and NAT1 haplotype.
Salazar-González RA; Turiján-Espinoza E; Hein DW; Niño-Moreno PC; Romano-Moreno S; Milán-Segovia RC; Portales-Pérez DP
Arch Toxicol; 2018 Feb; 92(2):661-668. PubMed ID: 29043425
[TBL] [Abstract][Full Text] [Related]
3. Functional polymorphism of the human arylamine N-acetyltransferase type 1 gene caused by C190T and G560A mutations.
Butcher NJ; Ilett KF; Minchin RF
Pharmacogenetics; 1998 Feb; 8(1):67-72. PubMed ID: 9511183
[TBL] [Abstract][Full Text] [Related]
4. Assessment of arylamine N-acetyltransferase (NAT1) activity in mononuclear leukocytes of cystic fibrosis patients.
Cribb AE; Tsui B; Isbrucker R; Michael RT; Gillespie CT; Brown-Bonomo J; Barrett P; Levatte T; Renton KW
Br J Clin Pharmacol; 1995 Jan; 39(1):85-9. PubMed ID: 7756106
[TBL] [Abstract][Full Text] [Related]
5. Arylamine N-acetyltransferase in human red blood cells.
Ward A; Hickman D; Gordon JW; Sim E
Biochem Pharmacol; 1992 Sep; 44(6):1099-104. PubMed ID: 1329759
[TBL] [Abstract][Full Text] [Related]
6. Arylamine N-acetyltransferase activity of the human placenta.
Derewlany LO; Knie B; Koren G
J Pharmacol Exp Ther; 1994 May; 269(2):756-60. PubMed ID: 8182542
[TBL] [Abstract][Full Text] [Related]
7. Correlation between genotype and phenotype of the human arylamine N-acetyltransferase type 1 (NAT1).
Bruhn C; Brockmöller J; Cascorbi I; Roots I; Borchert HH
Biochem Pharmacol; 1999 Dec; 58(11):1759-64. PubMed ID: 10571250
[TBL] [Abstract][Full Text] [Related]
8. Expression of monomorphic arylamine N-acetyltransferase (NAT1) in human leukocytes.
Cribb AE; Grant DM; Miller MA; Spielberg SP
J Pharmacol Exp Ther; 1991 Dec; 259(3):1241-6. PubMed ID: 1762071
[TBL] [Abstract][Full Text] [Related]
9. Acetylator phenotyping: the urinary caffeine metabolite ratio in slow acetylators correlates with a marker of systemic NAT1 activity.
Cribb AE; Isbrucker R; Levatte T; Tsui B; Gillespie CT; Renton KW
Pharmacogenetics; 1994 Jun; 4(3):166-70. PubMed ID: 7920698
[TBL] [Abstract][Full Text] [Related]
10. 4-Aminobiphenyl downregulation of NAT2 acetylator genotype-dependent N- and O-acetylation of aromatic and heterocyclic amine carcinogens in primary mammary epithelial cell cultures from rapid and slow acetylator rats.
Jefferson FA; Xiao GH; Hein DW
Toxicol Sci; 2009 Jan; 107(1):293-7. PubMed ID: 18842621
[TBL] [Abstract][Full Text] [Related]
11. Human placental transfer and metabolism of p-aminobenzoic acid.
Derewlany LO; Knie B; Koren G
J Pharmacol Exp Ther; 1994 May; 269(2):761-5. PubMed ID: 8182543
[TBL] [Abstract][Full Text] [Related]
12. Role of aromatic amine acetyltransferases, NAT1 and NAT2, in carcinogen-DNA adduct formation in the human urinary bladder.
Badawi AF; Hirvonen A; Bell DA; Lang NP; Kadlubar FF
Cancer Res; 1995 Nov; 55(22):5230-7. PubMed ID: 7585581
[TBL] [Abstract][Full Text] [Related]
13. Paclitaxel (taxol) inhibits the arylamine N-acetyltransferase activity and gene expression (mRNA NAT1) and 2-aminofluorene-DNA adduct formation in human bladder carcinoma cells (T24 and TSGH 8301).
Yang CC; Chen GW; Lu HF; Wang DY; Chen YS; Chung JG
Pharmacol Toxicol; 2003 Jun; 92(6):287-94. PubMed ID: 12787261
[TBL] [Abstract][Full Text] [Related]
14. A method for genotyping murine arylamine N-acetyltransferase type 2 (NAT2): a gene expressed in preimplantation embryonic stem cells encoding an enzyme acetylating the folate catabolite p-aminobenzoylglutamate.
Payton M; Smelt V; Upton A; Sim E
Biochem Pharmacol; 1999 Sep; 58(5):779-85. PubMed ID: 10449187
[TBL] [Abstract][Full Text] [Related]
15. Distribution of 2-aminofluorene and p-aminobenzoic acid N-acetyltransferase activity in tissues of C57BL/6J rapid and B6.A-NatS slow acetylator congenic mice.
Chung JG; Levy GN; Weber WW
Drug Metab Dispos; 1993; 21(6):1057-63. PubMed ID: 7905384
[TBL] [Abstract][Full Text] [Related]
16. Placental arylamine N-acetyltransferase type 1: potential contributory source of urinary folate catabolite p-acetamidobenzoylglutamate during pregnancy.
Upton A; Smelt V; Mushtaq A; Aplin R; Johnson N; Mardon H; Sim E
Biochim Biophys Acta; 2000 Dec; 1524(2-3):143-8. PubMed ID: 11113560
[TBL] [Abstract][Full Text] [Related]
17. Cyanamide-mediated Inhibition of N-acetyltransferase 1.
Dierolf D; Scheitza S; Bonifas J; Blömeke B
Toxicology; 2012 Dec; 302(1):1-10. PubMed ID: 22835378
[TBL] [Abstract][Full Text] [Related]
18. Inactivation of human arylamine N-acetyltransferase 1 by the hydroxylamine of p-aminobenzoic acid.
Butcher NJ; Ilett KF; Minchin RF
Biochem Pharmacol; 2000 Dec; 60(12):1829-36. PubMed ID: 11108798
[TBL] [Abstract][Full Text] [Related]
19. Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases.
Hein DW; Doll MA; Rustan TD; Gray K; Feng Y; Ferguson RJ; Grant DM
Carcinogenesis; 1993 Aug; 14(8):1633-8. PubMed ID: 8353847
[TBL] [Abstract][Full Text] [Related]
20. Monomorphic and polymorphic human arylamine N-acetyltransferases: a comparison of liver isozymes and expressed products of two cloned genes.
Grant DM; Blum M; Beer M; Meyer UA
Mol Pharmacol; 1991 Feb; 39(2):184-91. PubMed ID: 1996083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
